Market Value2,431,061,000
Total Holdings64
File Date2014-05-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ARAY / Accuray Incorporated
AEGR / Aegerion Pharmaceuticals, Inc.
AKRX / Akorn, Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
ALGN / Align Technology, Inc.
018490100 / Allergan plc
ANTH / Anthera Pharmaceuticals, Inc.
NLTX / Neoleukin Therapeutics, Inc.
ABBV / AbbVie Inc.
VRTX / Vertex Pharmaceuticals Incorporated
OMED / OptMed Inc
SHPG / Shire Plc.
HTWR / Heartware International Inc.
CELG / Celgene Corp.
CLDX / Celldex Therapeutics, Inc.
CLVS / Clovis Oncology Inc
SESN / Sesen Bio Inc.
US33830X1046 / Five Prime Therapeutics Inc
345838106 / Forest Laboratories Inc
GLYC / GlycoMimetics, Inc.
INGN / Inogen, Inc.
ICPT / Intercept Pharmaceuticals Inc
IRWD / Ironwood Pharmaceuticals, Inc.
US00C4U1L353 / Mylan N.V.
KERX / Keryx Biopharmaceuticals, Inc.
APEN / Apollo Endosurgery Inc
INCY / Incyte Corporation
RDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)
US60877T1007 / Momenta Pharmaceuticals, Inc.
NPSP / NPS Pharmaceuticals Inc
HALO / Halozyme Therapeutics, Inc.
NVS / Novartis AG - Depositary Receipt (Common Stock)
0PP / Portola Pharmaceuticals Inc
NXTM / NxStage Medical, Inc.
SGNT / Sagent Pharmaceuticals, Inc.
GEVA / Synageva Biopharma Corp
TNDM / Tandem Diabetes Care, Inc.
ABUS / Arbutus Biopharma Corporation
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
INVA / Innoviva, Inc.
91911K102 / Bausch Health Companies
WX / Wuxi Pharmatech (Cayman) Inc.
G0083B108 / Actavis
COV /
MNKKQ / Mallinckrodt Plc
WMGIZ / Wright Medical Group N.V.
UTHR / United Therapeutics Corporation
GILD / Gilead Sciences, Inc.
BIIB / Biogen Inc.
REGN / Regeneron Pharmaceuticals, Inc.
ISRG / Intuitive Surgical, Inc.
IONS / Ionis Pharmaceuticals, Inc.
AMGN / Amgen Inc.
BMRN / BioMarin Pharmaceutical Inc.
DXCM / DexCom, Inc.
ILMN / Illumina, Inc.
IMGN / ImmunoGen, Inc.
NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)
SGEN / Seagen Inc
MRK / Merck & Co., Inc.
PTCT / PTC Therapeutics, Inc.
TMO / Thermo Fisher Scientific Inc.
INSM / Insmed Incorporated
BSX / Boston Scientific Corporation